bk6_Hereditary Ataxia_aNORD Guides for Physicians #1 Th e N at io n al O rg an iz at io n f o r R ar e D is o rd er s This booklet is the first in a series of free publications

Hereditary tyrosinemia type I–associated mutations in fumarylacetoacetate hydrolase reduce the enzyme stability and increase its aggregation rateHereditary tyrosinemia

1060.tifH E R E D I T A R Y T Y R O S I N E M I A F o r m a t i o n o f S u c c i n y l a c e t o n e - A m i n o Acid A d d u c t s BY SHIGEO MANABE, SHIGERU SASSA, AND

014209_01 FST NBS Handbook of Metabolic Disorders Fact Sheet_TYRTyrosinemia Background Elevated blood Tyrosine levels are seen in three inherited disorders of Tyrosine metabolism.

js020000291pA Mouse Model of Renal Tubular Injury of Tyrosinemia Type 1: Development of de Toni Fanconi Syndrome and Apoptosis of Renal Tubular Cells inFah/HpdDouble Mutant

Hereditary Tyrosinemia and the Heme Biosynthetic Pathway. PROFOUND INHIBITION OF δ-AMINOLEVULINIC ACID DEHYDRATASE ACTIVITY BY SUCCINYLACETONE Shigeru Sassa, Attallah

2009119.930_933.tpClin Chem Lab Med 2009;47(8):930–933 2009 by Walter de Gruyter • Berlin • New York. DOI 10.1515/CCLM.2009.223 2007/119 Article in press